BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23108832)

  • 21. Indications and contraindications of auditory brainstem implants: systematic review and illustrative cases.
    Merkus P; Di Lella F; Di Trapani G; Pasanisi E; Beltrame MA; Zanetti D; Negri M; Sanna M
    Eur Arch Otorhinolaryngol; 2014 Jan; 271(1):3-13. PubMed ID: 23404468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation.
    Vincenti V; Pasanisi E; Guida M; Di Trapani G; Sanna M
    Audiol Neurootol; 2008; 13(4):273-80. PubMed ID: 18259080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical application of the multichannel auditory brainstem implant].
    Wu H; Sterkers O; Rey A; Bouccara D
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):123-5. PubMed ID: 12768669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
    Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
    Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Auditory brainstem implant: indications and results].
    Bouccara D; Kalamarides M; Bozorg Grayeli A; Ambert-Dahan E; Rey A; Sterkers O
    Ann Otolaryngol Chir Cervicofac; 2007 Jul; 124(3):148-54. PubMed ID: 17320034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Auditory brainstem implantation].
    Hansen JO; West N; Bille M; Cayé-Thomasen P
    Ugeskr Laeger; 2021 Jan; 183(3):. PubMed ID: 33491645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auditory Brainstem Implantation in Chinese Patients With Neurofibromatosis Type II: The Hong Kong Experience.
    Thong JF; Sung JK; Wong TK; Tong MC
    Otol Neurotol; 2016 Aug; 37(7):956-62. PubMed ID: 27273391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation.
    Jia H; Nguyen Y; Hochet B; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
    Otol Neurotol; 2020 Jan; 41(1):94-99. PubMed ID: 31634276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auditory brainstem implants: current state and future directions with special reference to the subtonsillar approach for implantation.
    Seki Y; Samejima N; Komatsuzaki A
    Acta Neurochir Suppl; 2007; 97(Pt 2):431-5. PubMed ID: 17691332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auditory brainstem implant outcomes and MAP parameters: report of experiences in adults and children.
    Goffi-Gomez MV; Magalhães AT; Brito Neto R; Tsuji RK; Gomes Mde Q; Bento RF
    Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):257-64. PubMed ID: 22226602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auditory brainstem implantation (ABI) in children without neurofibromatosis type II (NF2): communication performance and safety after 24 months of use.
    Rajeswaran R; Kameswaran M
    Cochlear Implants Int; 2020 May; 21(3):127-135. PubMed ID: 31847793
    [No Abstract]   [Full Text] [Related]  

  • 34. The auditory midbrain implant: a new auditory prosthesis for neural deafness-concept and device description.
    Lenarz T; Lim HH; Reuter G; Patrick JF; Lenarz M
    Otol Neurotol; 2006 Sep; 27(6):838-43. PubMed ID: 16936570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bimodal stimulation in children with inner ear malformation: One side cochlear implant and contralateral auditory brainstem implant.
    Batuk MO; Cinar BC; Yarali M; Aslan F; Ozkan HB; Sennaroglu G; Yucel E; Bajin MD; Bilginer B; Sennaroglu L
    Clin Otolaryngol; 2020 Mar; 45(2):231-238. PubMed ID: 31854074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A report of three cases and review of auditory brainstem implants in children].
    Couloigner V; Gratacap M; Ambert-Dahan E; Borel S; Ettienne V; Kerouedan A; Bouccara D; Zerah M; Kalamarides M; Sterkers O
    Neurochirurgie; 2014; 60(1-2):17-26. PubMed ID: 24656883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New outcomes with auditory brainstem implants in NF2 patients.
    Behr R; Colletti V; Matthies C; Morita A; Nakatomi H; Dominique L; Darrouzet V; Brill S; Shehata-Dieler W; Lorens A; Skarzynski H
    Otol Neurotol; 2014 Dec; 35(10):1844-51. PubMed ID: 25325841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auditory brainstem implant (ABI): new frontiers in adults and children.
    Colletti V; Carner M; Miorelli V; Guida M; Colletti L; Fiorino F
    Otolaryngol Head Neck Surg; 2005 Jul; 133(1):126-38. PubMed ID: 16025066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
    Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
    Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.